43.Which country has launched a clinical trial evaluating HIV vaccines based on mRNA platform?
Q. Which country has launched a clinical trial evaluating HIV vaccines based on mRNA platform? Answer: [D] USA Notes: The US-based National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial to evaluate three experimental HIV vaccines based on a messenger RNA (mRNA) platform. It is the technology used in several approved COVID-19 vaccines. This study named HVTN 302 is sponsored by NIAID while the NIAID-funded HIV Vaccine Trials Network is conducting the trial.
